Garofalo Health Care S.p.A. (BIT:GHC)
5.60
+0.10 (1.82%)
Last updated: Jul 28, 2026, 10:16 AM CET
Garofalo Health Care Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16.53 | 19.89 | 26.66 | 22.68 | 31.38 | 41.24 |
Short-Term Investments | 10.8 | 10.55 | 5.48 | 0.41 | 0.22 | 0.18 |
Cash & Short-Term Investments | 27.33 | 30.43 | 32.15 | 23.09 | 31.6 | 41.41 |
Cash Growth | -10.21% | -5.33% | 39.20% | -26.91% | -23.71% | 66.06% |
Accounts Receivable | 128.18 | 117.75 | 112.84 | 100.99 | 76.48 | 74.72 |
Other Receivables | 15.78 | 13.16 | 13.42 | 15.59 | 9.07 | 9.49 |
Total Trade Receivables | 143.95 | 130.91 | 126.26 | 116.59 | 85.55 | 84.21 |
Inventory | 6.25 | 6.22 | 6.07 | 5.58 | 4.24 | 4.32 |
Total Current Assets | 177.53 | 167.56 | 164.48 | 145.26 | 121.39 | 129.95 |
Net Property, Plant & Equipment | 311.36 | 301.37 | 293.79 | 252.99 | 221.83 | 217.01 |
Other Intangible Assets | 282.19 | 281.83 | 281.45 | 219.26 | 196.04 | 195.83 |
Goodwill | 108.41 | 91.54 | 91.54 | 156.01 | 91.39 | 70.27 |
Long-Term Investments | 3.71 | 2.98 | 2.76 | 4.75 | 1.34 | 1.77 |
Other Long-Term Assets | 14.28 | 14.53 | 16.2 | 17.93 | 13.83 | 11.7 |
Total Assets | 897.48 | 859.82 | 850.22 | 796.2 | 645.82 | 626.51 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 89.84 | 82.22 | 86.41 | 87.85 | 51.1 | 46.24 |
Accrued Expenses | 9.59 | 6.07 | 3.68 | 4.48 | 3.21 | 3.86 |
Short-Term Debt | 7.88 | 6.17 | 6.75 | 64.64 | 44.44 | 45.66 |
Other Current Liabilities | 47.29 | 42.13 | 48 | 47.44 | 32.48 | 34.43 |
Total Current Liabilities | 154.59 | 136.58 | 144.85 | 204.41 | 131.24 | 130.19 |
Long-Term Debt | 227.66 | 220.2 | 224.42 | 164.2 | 132.17 | 138.13 |
Other Long-Term Liabilities | 156.42 | 153.25 | 147.81 | 126.71 | 103.27 | 97.48 |
Total Long-Term Liabilities | 384.08 | 373.45 | 372.23 | 290.91 | 235.43 | 235.61 |
Total Liabilities | 538.67 | 510.03 | 517.07 | 495.31 | 366.67 | 365.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 31.57 | 31.57 | 31.57 | 31.57 | 31.57 | 31.57 |
Retained Earnings | 359.04 | 307.34 | 290.83 | 267.32 | 247.5 | 228.88 |
Total Common Shareholders' Equity | 347.92 | 338.91 | 322.4 | 298.89 | 279.07 | 260.45 |
Minority Interest | 0.4 | 10.88 | 10.75 | 2 | 0.08 | 0.26 |
Shareholders' Equity | 358.82 | 349.79 | 333.14 | 300.89 | 279.15 | 260.72 |
Total Liabilities & Equity | 897.48 | 859.82 | 850.22 | 796.2 | 645.82 | 626.51 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 235.54 | 226.36 | 231.17 | 228.84 | 176.61 | 183.79 |
Net Cash (Debt) | -208.22 | -195.93 | -199.03 | -205.74 | -145.01 | -142.38 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.36 | -2.21 | -2.25 | -2.32 | -1.63 | -1.60 |
Book Value | 347.92 | 338.91 | 322.4 | 298.89 | 279.07 | 260.45 |
Book Value Per Share | 3.94 | 3.83 | 3.64 | 3.38 | 3.14 | 2.92 |
Tangible Book Value | -42.68 | -34.47 | -50.59 | -76.38 | -8.36 | -5.64 |
Tangible Book Value Per Share | -0.48 | -0.39 | -0.57 | -0.86 | -0.09 | -0.06 |